Filing metadata

Accession number
0001104659-26-030841
Form type
Form 3
Filer
AgomAb Therapeutics NV
CIK
CIK 2020932
Filed
Mar 18, 2026
Reporting period
Mar 18, 2026
Description
Initial ownership

Explore SEC Filings Hub

3 | SEC Filings Hub